Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2024
--
Maximum
Jun 2024
--
Average
--
Median
Jun 2024
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7605 |
| Myomo Inc | 0.00 |
| Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 600.81M |
| Total Liabilities (Quarterly) | 45.34M |
| Shareholders Equity (Quarterly) | 555.46M |
| Current Ratio | 14.62 |